An observational study in Tantalum, Bone Loss and Allograft, sponsored by University Hospital, Montpellier. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-08-22.
Sponsored by University Hospital, Montpellier · Observational
A new surgical technique of reconstruction for bone loss in TKA revision using tantalum cone and allograft.
Study of radiological and clinical outcomes.
University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pregnant women attending for 3rd timester scan
Exclusion criteria:
Rate of Survivorship of the implant
Survivorship of the implant
Time frame: day 1
Plan to share: Undecided — NC
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier